Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
48.19
+0.07 (0.15%)
Aug 27, 2025, 4:00 PM - Market closed
Akero Therapeutics Employees
Akero Therapeutics had 63 employees as of December 31, 2024. The number of employees increased by 7 or 12.50% compared to the previous year.
Employees
63
Change (1Y)
7
Growth (1Y)
12.50%
Revenue / Employee
n/a
Profits / Employee
-$4,507,286
Market Cap
3.85B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 63 | 7 | 12.50% |
Dec 31, 2023 | 56 | 17 | 43.59% |
Dec 31, 2022 | 39 | 5 | 14.71% |
Dec 31, 2021 | 34 | 12 | 54.55% |
Dec 31, 2020 | 22 | 8 | 57.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AKRO News
- 13 days ago - Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASH - GlobeNewsWire
- 19 days ago - Akero Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Shareholders to Inquire about Securities Investigation - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to Connect - Accesswire
- 3 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to Reach Out - Accesswire
- 3 months ago - Akero Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 3 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Stockholders to Inquire about Securities Investigation - Accesswire